BA (Cum Laude), MA, MSc, PhD
Post-doctoral Researcher (Part-time)
- Mixed Methods Researcher for IMI PARADIGM
- Qualitative Researcher for Oxford-Celgene Clinical Research Fellow Programme project
Centre for the Advancement of Sustainable Medical Innovation
I am a post-doctoral researcher in the Interdisciplinary Research in Health Sciences (IRIHS) Group in the Department of Primary Care Health Sciences and the Centre for the Advancement of Sustainable Medical Innovation (CASMI). Currently, I am part of a 30-month, EU-wide consortium project called IMI PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines). I am using quantitative and qualitative methodologies to understand the current patient engagement landscape in the medicines lifecycle among nine stakeholder groups.
I am also the lead researcher on the Oxford-Celgene Clinical Research Fellowship Programme. My focus is on understanding the potential for clinical and academic research fellows to become boundary spanners by gaining experience through an industry-funded fellowship programme. The study is a multi-phase 3-year longitudinal project and mixes qualitative methods, evaluation tools and life journey plots to understand the career, aspirations, network and relationships of the Fellows. There is also a formative assessment conducted that asks the Fellows, Principal Investigators and Industry Mentors their thoughts on the programme and how it can be improved.
My previous work explored perceptions of tri-sectoral collaborations between academia, healthcare and industry to understand the barriers and facilitators to medical innovation adoption in the NHS. We applied knowledge mobilisation theory to develop recommendations for current innovation adoption policies.
Cancer as the "perfect storm"? A qualitative study of public attitudes to health conditions.
Morrell L. et al, (2018), Health Sci Rep, 1
Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption
Ii SS. et al, (2017), Health Policy
Diet and nutrient intake of people receiving opioid agonist treatment (OAT): implications for recovery
Ii SS. et al, (2016), Drugs and Alcohol Today, 16, 59 - 71